“As urologists, we see men of all ages, and one of the things that we need to do is…take advantage of being their advocates for health care,” says Michael Lutz, MD.
In this episode, Urology Times® Assistant Managing Editor Ben Saylor spoke with Dr. Michael Lutz about how urologists can be advocates for men’s health. Lutz is a partner in the Michigan Institute of Urology and president of the MIU Men’s Health Foundation.
ECLIPSE trial evaluating PSMA agent for metastatic castration-resistant prostate cancer
August 30th 2023"The purpose of the study is to compare the safety and efficacy of lutetium PSMA I&T vs standard of care hormone therapy in patients with metastatic castration-resistant prostate cancer," says Jason M. Hafron, MD.